Medicare Enrolled
Dr. Faina Akselrod, M.D.
Obstetrics & Gynecology · East Meadow, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Akselrod from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Akselrod?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Akselrod
Dr. Faina Akselrod is an obstetrics & gynecology specialist in East Meadow, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Akselrod performed 3,934 Medicare services across 3,316 unique beneficiaries.
Between the years covered by Open Payments, Dr. Akselrod received a total of $2,854 from 28 pharmaceutical and/or device companies across 139 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in obstetrics & gynecology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Akselrod is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in NY
$2,854 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,934
Medicare services
Top 0% in NY for obstetrics & gynecology
3,316
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~197 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Transvaginal pelvic ultrasound An ultrasound exam using a probe inserted into the vagina to image the uterus, ovaries, fallopian tubes, cervix, and surrounding pelvic structures. |
626 | $115 | $350 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
549 | $103 | $300 |
| HPV high-risk type nucleic acid test A laboratory test that uses nucleic acid detection to identify high-risk types of human papillomavirus. |
450 | $34 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
401 | $82 | $130 |
| Principal care management for high-risk disease, first 30 minutes This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month. |
269 | $74 | $100 |
| Pelvic and clinical breast exam for cancer screening A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider. |
217 | $48 | $80 |
| Pap smear screening test A screening test to collect and prepare a cervical or vaginal sample for laboratory analysis. |
216 | $52 | $80 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
189 | $51 | $100 |
| Fitting and insertion of vaginal support device A procedure to measure, fit, and insert a device designed to support vaginal structures. |
170 | $71 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
112 | $106 | $199 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
82 | $4 | $10 |
| Candida yeast detection test A laboratory test that uses a direct probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
72 | $20 | $50 |
| Gardnerella vaginalis detection test A laboratory test that uses a direct probe technique to detect the presence of Gardnerella vaginalis bacteria. |
72 | $20 | $50 |
| Trichomonas vaginalis nucleic acid test A laboratory test that uses a direct probe technique to detect the genetic material of the Trichomonas vaginalis parasite. |
72 | $20 | $50 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
68 | $53 | $100 |
| Chlamydia trachomatis nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Chlamydia trachomatis bacteria in a sample. |
46 | $34 | $60 |
| Gonorrhea nucleic acid amplification test A laboratory test that uses amplified probe techniques to detect the genetic material of gonorrhea bacteria. This method identifies the presence of the infection by analyzing nucleic acids from the sample. |
46 | $34 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $113 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
41 | $146 | $250 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
40 | $8 | $15 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
33 | $47 | $198 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
30 | $139 | $350 |
| Non-rubber pessary A non-rubber device inserted into the vagina to support pelvic organs. |
23 | $52 | $100 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
22 | $17 | $200 |
| HPV DNA test for types 16 and 18 A laboratory test that uses nucleic acid detection to identify the presence of human papillomavirus types 16 and 18. |
18 | $40 | $100 |
| Cervical biopsy and scraping via endoscope This procedure involves using an endoscope to visualize the cervix while performing a biopsy and scraping to collect tissue samples for examination. |
13 | $169 | $500 |
| Endometrial biopsy or polyp removal A procedure to collect a tissue sample from the uterine lining or remove a polyp using a thin, lighted tube inserted through the cervix. |
13 | $1,337 | $2,000 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,854
Total received (2018-2024)
Avg $408/year across 7 years
Top 14% in NY for obstetrics & gynecology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
139
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,702 (94.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$152 (5.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$544
2023
$433
2022
$545
2021
$431
2020
$320
2019
$286
2018
$294
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$146
PFIZER INC.
$80
CooperSurgical, Inc.
$79
Astellas Pharma US Inc
$65
Exeltis, USA Inc.
$53
Evofem Biosciences, Inc.
$44
MAYNE PHARMA COMMERCIAL LLC
$34
Novo Nordisk Inc
$22
Organon Llc
$21
Top 3 companies account for 55.9% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$282
Astellas Pharma US Inc
$280
Sumitomo Pharma America, Inc.
$273
PFIZER INC.
$273
CooperSurgical, Inc.
$201
AbbVie, Inc.
$171
AMAG Pharmaceuticals, Inc.
$152
UROVANT SCIENCES INC
$124
ABBVIE INC.
$119
Evofem Biosciences, Inc.
$110
TherapeuticsMD, Inc.
$109
Novo Nordisk Inc
$99
Myovant Sciences Inc.
$85
Avion Pharmaceuticals
$82
Merck Sharp & Dohme Corporation
$79
Exeltis, USA Inc.
$69
MAYNE PHARMA COMMERCIAL LLC
$56
Hologic, LLC
$51
Duchesnay USA Incorporated
$46
Lupin Inc.
$32
SCYNEXIS, Inc.
$25
Mylan Pharmaceuticals Inc.
$25
Organon Llc
$21
Shield Therapeutics Inc
$21
Organon LLC
$20
Allergan Inc.
$18
Agile Therapeutics, Inc.
$15
MILLICENT US INC
$15
Top 3 companies account for 29.3% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ANNOVERA · APTIMA · Balcoltra · COLOGUARD · Diclegis · Femring · GEMTESA · IMVEXXY · INTRAROSA · LO LOESTRIN FE · MYFEMBREE · MYRBETRIQ · Myrbetriq · NEXPLANON · NEXTSTELLIS · ORIAHNN · ORILISSA · Orilissa · Osphena · Ozempic · PARAGARD T 380A · PREMARIN · Paragard · Paragard T 380A · Phexxi · SLYND · SOLOSEC · THINPREP 2000 PROCESSOR · Twirla · Veozah · Vitafol One · Xulane
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Obstetricians & gynecologists within 10 mi
1,958
Per 100K population
141.1
County median income
$143,408
Nearest hospital
NASSAU UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Akselrod is a clinical cardiology specialist, with above-average Medicare volume (top 0% in NY), with low-engagement industry engagement in the top 14% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Akselrod experienced with transvaginal pelvic ultrasound?
Based on Medicare claims data, Dr. Akselrod performed 626 transvaginal pelvic ultrasound services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Akselrod receive payments from pharmaceutical companies?
Yes. Dr. Akselrod received a total of $2,854 from 28 companies across 139 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Akselrod's costs compare to other obstetricians & gynecologists in East Meadow?
Dr. Akselrod's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Akselrod) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Obstetricians & Gynecologists in East Meadow
Browse obstetricians & gynecologists in East Meadow ranked by procedure volume and transparency data.
Highest volume
Top Obstetricians & Gynecologists in NY
Obstetricians & gynecologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Obstetricians & Gynecologists in NY
Which NY obstetricians & gynecologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Sumitomo Pharma America, Inc. Payments to Doctors
See all physicians who received payments from Sumitomo Pharma America, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology